Clinical Trial

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2024 (before its estimated October 9, 2025 completion). Its status may not reflect the trial's current state.
Summary
The trial is open to all patients with a diagnosis of acute promyelocytic leukemia (APL) who are PCR-positive for the PML-RARα transcript and less than 18 years of age.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-03-10; most recent amendment 2024-04-12.
Trial Details
NCT Number NCT04793919
Lead Sponsor Associazione Italiana Ematologia Oncologia Pediatrica
Conditions Acute Promyelocytic Leukemia
Enrollment 89 participants
Start Date 2019-10-09
Primary Completion 2025-10-09 (estimated)
Study Completion 2027-10-10 (estimated)
Updated on ClinicalTrials.gov 2024-04-15